Persistent Activation of Renal Autophagy Contributes to Nephropathy in Murine Glycogen Storage Disease Type Ia
Journal of Inherited Metabolic Disease · 2026
DOI: 10.1002/jimd.70127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von Cheol Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section on Cellular Differentiation, Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Developm…. Hauptthemen laut MEDLINE: Autophagy, Glycogen Storage Disease Type I, Kidney, Kidney Diseases. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Kidney disease in glycogen storage disease type Ia (GSD‐Ia), deficient in glucose‐6‐phosphatase‐α (G6Pase‐α), is associated with acute kidney injury (AKI) and renal fibrosis. During AKI, autophagy is typically activated to eliminate protein aggregates and damaged organelles; however, sustained autophagy can contribute to maladaptive repair and fibrosis. Using a GSD‐Ia mouse model, we demonstrate that renal G6Pase‐α deficiency results in heightened autophagy activation, as indicated by increased expression of multiple autophagy‐related components and enhanced autophagic flux. Notably, both positive regulators of autophagy, including sirtuin‐1, forkhead box O3a, and AMP‐activated protein kinase, as well as the key negative regulator, mammalian target of rapamycin (mTOR), were concurrently activated in the kidneys of GSD‐Ia mice. Previous studies have shown that in response to AKI, renal levels of cyclin G1 (CG1) and cyclin‐dependent kinase 5 (CDK5) increase, promoting maladaptive dedifferentiation, G2/M cell cycle arrest in proximal tubular epithelial cells, and the formation of a TOR‐autophagy spatial coupling compartment. This sequence of events contributes to profibrotic factor production and accelerates the progression of kidney disease. In this study, we observed a significant elevation of renal CG1 and CDK5 in GSD‐Ia mice with enhanced autophagy, suggesting a potential mechanistic link to the development of renal fibrosis in GSD‐Ia. A deeper understanding of these pathways may facilitate the development of targeted therapies for GSD‐Ia nephropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section on Cellular Differentiation, Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
- Section on Cellular Neurobiology, Division of Molecular and Cellular Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Brian C Mansfield, Janice Y Chou
Förderung
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Lee, C., Pratap, K., Gautam, S., Zhang, L., Chen, H. D., Loh, Y. P., Mansfield, B. C., & Chou, J. Y. (2026). Persistent Activation of Renal Autophagy Contributes to Nephropathy in Murine Glycogen Storage Disease Type Ia. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70127
Vancouver
Lee C, Pratap K, Gautam S, Zhang L, Chen HD, Loh YP, et al. Persistent Activation of Renal Autophagy Contributes to Nephropathy in Murine Glycogen Storage Disease Type Ia. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70127
BibTeX
@article{Lee2026,
author = {Lee, Cheol and Pratap, Kunal and Gautam, Sudeep and Zhang, Lisa and Chen, Hung Dar and Loh, Yoke Peng and Mansfield, Brian C and Chou, Janice Y},
title = {Persistent Activation of Renal Autophagy Contributes to Nephropathy in Murine Glycogen Storage Disease Type Ia},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
doi = {10.1002/jimd.70127}
}
EUVIMED